...
首页> 外文期刊>Clinical nutrition >Diamine oxidase (DAO) supplement reduces headache in episodic migraine patients with DAO deficiency: A randomized double-blind trial
【24h】

Diamine oxidase (DAO) supplement reduces headache in episodic migraine patients with DAO deficiency: A randomized double-blind trial

机译:二胺氧化酶(DAO)补充剂减少了DAO缺乏的情节偏头痛患者的头痛:随机双盲试验

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background & aims: Histamine intolerance is a disorder in the homeostasis of histamine due to a reduced intestinal degradation of this amine, mainly caused by a deficiency in the enzyme diamine oxidase (DAO). Among histamine related symptoms, headache is one of the most recorded. Current clinical strategies for the treatment of the symptomatology related to this disorder are based on the exclusion of foods with histamine or other bioactive amines and/or exogenous DAO supplementation. The aim of this study was to assess the efficacy of a food supplement consisting of DAO enzyme as a preventive treatment of migraine in patients with DAO deficiency through a randomized double-blind trial.
机译:背景和目标:组胺不耐受是由于该胺的肠道降解降低,组胺的稳态中的一种疾病,主要是由酶二胺氧化酶(DAO)的缺陷引起的。 在组胺相关症状中,头痛是最录制的。 目前用于治疗与该疾病有关的症状学的临床策略基于与组胺或其他生物活性胺和/或外源DAO补充的食物排除。 本研究的目的是评估由DAO酶组成的食物补充剂,作为通过随机双盲试验进行DAO缺乏症患者偏头痛的预防治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号